Towards first-in-class siRNA therapeutics for adrenal targets

• Unité de recherche: INNOSUISSE
• Numéro de projet: 134.630 IP-LS
• Titre du projet anglais: Towards first-in-class siRNA therapeutics for adrenal targets

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

We aim to develop first-in-class siRNA drug candidates for adrenal targets using Procavea's proprietary, protein-based delivery platform. The pre-clinical data generated will serve to further validate the technology platform, bringing it closer to commercialization.